Laura Simon Treml
Corporate Officer/Principal bij ARATANA THERAPEUTICS INC
Actieve functies van Laura Simon Treml
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26-03-2013 | - |
Loopbaan van Laura Simon Treml
Opleiding van Laura Simon Treml
University of Pennsylvania | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Beurs
- Insiders
- Laura Simon Treml
- Ervaring